NO955074D0 - 1-substituted istain and oxindole derivatives as inhibitors of acetylcholinesterase - Google Patents

1-substituted istain and oxindole derivatives as inhibitors of acetylcholinesterase

Info

Publication number
NO955074D0
NO955074D0 NO955074A NO955074A NO955074D0 NO 955074 D0 NO955074 D0 NO 955074D0 NO 955074 A NO955074 A NO 955074A NO 955074 A NO955074 A NO 955074A NO 955074 D0 NO955074 D0 NO 955074D0
Authority
NO
Norway
Prior art keywords
istain
acetylcholinesterase
inhibitors
substituted
oxindole derivatives
Prior art date
Application number
NO955074A
Other languages
Norwegian (no)
Other versions
NO955074L (en
Inventor
Bernard Robin Boar
Dennis Mark O'shea
Ian David Tomlinson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO955074D0 publication Critical patent/NO955074D0/en
Publication of NO955074L publication Critical patent/NO955074L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO955074A 1993-06-16 1995-12-14 1-substituted istain and oxindole derivatives as inhibitors of acetylcholinesterase NO955074L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302080A SE9302080D0 (en) 1993-06-16 1993-06-16 NEW COMPOUNDS
PCT/SE1994/000448 WO1994029272A1 (en) 1993-06-16 1994-05-13 1-substituted isatin and oxindole derivatives as inhibitors of acetylcholinesterase

Publications (2)

Publication Number Publication Date
NO955074D0 true NO955074D0 (en) 1995-12-14
NO955074L NO955074L (en) 1996-02-07

Family

ID=20390305

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955074A NO955074L (en) 1993-06-16 1995-12-14 1-substituted istain and oxindole derivatives as inhibitors of acetylcholinesterase

Country Status (9)

Country Link
EP (1) EP0703901A1 (en)
JP (1) JPH08511515A (en)
AU (1) AU7010894A (en)
CA (1) CA2164119A1 (en)
FI (1) FI956074A0 (en)
IS (1) IS4167A (en)
NO (1) NO955074L (en)
SE (1) SE9302080D0 (en)
WO (1) WO1994029272A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103752D0 (en) * 1991-12-18 1991-12-18 Astra Ab NEW COMPOUNDS
CN100391455C (en) 1998-03-06 2008-06-04 阿斯特拉曾尼卡有限公司 New use
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
HUP0104493A3 (en) 1998-09-30 2002-12-28 Takeda Pharmaceutical Drugs for improving vesical excretory strength
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
EP1370527A1 (en) 2001-03-06 2003-12-17 AstraZeneca AB Indolone derivatives having vascular-damaging activity
TW200508197A (en) 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
AU2005250103A1 (en) * 2004-05-27 2005-12-15 Ucb Benzoxazolone derivatives, processes for preparing them and their uses
US7632856B2 (en) 2004-07-22 2009-12-15 Ucb Pharma, S.A. Indolone derivatives, processes for preparing them and their uses
GT200500185A (en) 2004-08-09 2006-04-10 PROGESTERONE RECEIVER MODULATORS UNDERSTANDING PIRROL-OXINDOL DERIVATIVES AND THEIR USES
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists
EA202092673A3 (en) 2010-02-09 2021-05-31 Дзе Джонс Хопкинс Юниверсити METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
GEP201706739B (en) 2012-12-13 2017-09-25 H Lundbeck As Compositions comprising vortioxetine and donepezil
CN105142623A (en) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 Methods and compositions for improving cognitive function
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins Methods and compositions for improving cognitive function
CN104530065A (en) * 2013-05-13 2015-04-22 江西科技师范大学 1-N acyl substituent indolone derivative application
CN103242332B (en) * 2013-05-13 2015-11-04 江西科技师范大学 1-N acyl substituted indolone derivatives
EA034167B8 (en) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH491106A (en) * 1964-06-11 1970-05-31 Ciba Geigy Process for the production of new thiosemicarbazones

Also Published As

Publication number Publication date
IS4167A (en) 1994-12-17
JPH08511515A (en) 1996-12-03
NO955074L (en) 1996-02-07
FI956074A (en) 1995-12-18
AU7010894A (en) 1995-01-03
CA2164119A1 (en) 1994-12-22
WO1994029272A1 (en) 1994-12-22
SE9302080D0 (en) 1993-06-16
FI956074A0 (en) 1995-12-18
EP0703901A1 (en) 1996-04-03

Similar Documents

Publication Publication Date Title
NO955074D0 (en) 1-substituted istain and oxindole derivatives as inhibitors of acetylcholinesterase
FI974436A0 (en) Substituted N- (indole-2-carbonyl) -glycinamides and derivatives as glycogen phosphorylase inhibitors
DK1475377T3 (en) Indole derivatives and their use as inhibitors of phosphodiesterase 4
HUP0004490A2 (en) Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threoning kinase inhibitors and pharmaceutical compositions containing them
NO975245D0 (en) Heterocycles as inhibitors of leukocyte adhesion and VLA-4 antagonists
IL126674A0 (en) Urea derivatives as inhibitors of impdh enzyme and pharmaceutical compositions containing the same
PL341400A1 (en) Derivatives of indole as inhibitors of factor xa
NO973479L (en) Substituted heterocyclic compounds, method of preparation and pharmaceutical compositions containing the same
DK0832066T3 (en) Substituted N- (indole-2-carbonyl) amides and derivatives as glycogen phosphorylase inhibitors
NO962269D0 (en) Enzyme inhibitors
FI940393A (en) Quinazoline derivatives as acetylcholinesterase inhibitors
HUP0104987A2 (en) Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
AU6157396A (en) Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors
PL331047A1 (en) Novel amidinic derivatives and their application as inhibitors of thrombosin
AU1271297A (en) Inhibitor of ceramidase
NO942994L (en) Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE
DK0892796T3 (en) Isatin derivatives such as acetylcholinesterase inhibitors and analgesics
PL337645A1 (en) Novel amidine derivatives and their application as thrombosin inhibitors
NO923089D0 (en) TETRAHYDROINDAZOL, TETRAHYDROCYCLOPENTAPYRAZOL AND HEXSAHYDROCYCLOHEPTAPYRAZOL COMPOUNDS AND THEIR USE AS HMG-COA REDUCTASE INHIBITORS
NO961475D0 (en) Indole derivatives
PT934280E (en) DERIVATIVES 2-CYANOIMINOIMIDAZOLE PDE IV INHIBITORS
NO980718D0 (en) Bicyclic 4-aralkylaminopyrimidine derivatives and tyrosine kinase inhibitors
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
DE69431454D1 (en) Amylase inhibitors